Choroidal thickness changes after intravitreal antivascular endothelial growth factor therapy for age-related macular degeneration: Ranibizumab versus aflibercept / Gharbiya, M., Cruciani, F., Mariotti, C., Grandinetti, F., Marenco, M., Cacace, V.. - In: JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS. - ISSN 1080-7683. - 31:6(2015), pp. 357-362. [10.1089/jop.2014.0160]
Choroidal thickness changes after intravitreal antivascular endothelial growth factor therapy for age-related macular degeneration: Ranibizumab versus aflibercept
MARIOTTI, Cesare;
2015-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


